{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:26:46Z","timestamp":1788280006799,"version":"build-2803163510"},"reference-count":17,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Cystatin C is becoming an increasingly popular biomarker for estimating glomerular filtration rate, and accurate measurements of cystatin C concentrations are necessary for accurate estimates of glomerular filtration rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the accuracy of cystatin C concentration measurements in laboratories participating in the College of American Pathologists CYS Survey.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Two fresh frozen serum pools, the first from apparently healthy donors and the second from patients with chronic kidney disease, were prepared and distributed to laboratories participating in the CYS Survey along with the 2 usual processed human plasma samples. Target values were established for each pool by using 2 immunoassays and ERM DA471\/IFCC international reference material.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>For the normal fresh frozen pool (ERM-DA471\/IFCC\u2013traceable target of 0.960 mg\/L), the all-method mean (SD, % coefficient of variation [CV]) reported by all of the 123 reporting laboratories was 0.894 mg\/L (0.128 mg\/L, 14.3%). For the chronic kidney disease pool (ERM-DA471\/IFCC\u2013traceable target of 2.37 mg\/L), the all-method mean (SD, %CV) was 2.258 mg\/L (0.288 mg\/L, 12.8%). There were substantial method-specific biases (mean milligram per liter reported for the normal pool was 0.780 for Siemens, 0.870 for Gentian, 0.967 for Roche, 1.061 for Diazyme, and 0.970 for other\/not specified reagents; and mean milligram per liter reported for the chronic kidney disease pool was 2.052 for Siemens, 2.312 for Gentian, 2.247 for Roche, 2.909 for Diazyme, and 2.413 for other\/not specified reagents).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Manufacturers need to improve the accuracy of cystatin C measurement procedures if cystatin C is to achieve its full potential as a biomarker for estimating glomerular filtration rate.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2014-0427-cp","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T13:44:39Z","timestamp":1429278279000},"page":"888-893","source":"Crossref","is-referenced-by-count":66,"title":["Performance in Measurement of Serum Cystatin C by Laboratories Participating in the College of American Pathologists 2014 CYS Survey"],"prefix":"10.5858","volume":"139","author":[{"given":"John H.","family":"Eckfeldt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy B.","family":"Karger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Greg","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Rynders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Inker","sequence":"additional","affiliation":[{"name":"From the Department of Laboratory Medicine and Pathology (Drs Eckfeldt and Karger)"},{"name":"and the Advanced Research and Diagnostic Laboratory (Mr Rynders),"},{"name":"University of Minnesota, Minneapolis; the Department of Pathology, Virginia Commonwealth University, Richmond (Dr Miller);"},{"name":"and the Division of Nephrology, Tufts Medical Center, Boston, Massachusetts (Dr Inker)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2015,4,17]]},"reference":[{"issue":"1","key":"2020081222332007800_i1543-2165-139-7-888-b01","first-page":"1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"2020081222332007800_i1543-2165-139-7-888-b02","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"2020081222332007800_i1543-2165-139-7-888-b03","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1373\/clinchem.2013.220707","article-title":"Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator","volume":"60","author":"Grubb","year":"2014","journal-title":"Clin Chem"},{"issue":"7","key":"2020081222332007800_i1543-2165-139-7-888-b04","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1373\/clinchem.2014.225383","article-title":"Cystatin C for glomerular filtration rate estimation: coming of age","volume":"60","author":"Levey","year":"2014","journal-title":"Clin Chem"},{"issue":"10","key":"2020081222332007800_i1543-2165-139-7-888-b05","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"2020081222332007800_i1543-2165-139-7-888-b06","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2012.04.012","article-title":"Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"60","author":"Anderson","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"2020081222332007800_i1543-2165-139-7-888-b07","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7326\/0003-4819-157-7-201210020-00003","article-title":"Two novel equations to estimate kidney function in persons aged 70 years or older","volume":"157","author":"Schaeffner","year":"2012","journal-title":"Ann Intern Med"},{"issue":"6","key":"2020081222332007800_i1543-2165-139-7-888-b08","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2020081222332007800_i1543-2165-139-7-888-b09","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2012.07.007","article-title":"GFR estimation using standardized serum cystatin C in Japan","volume":"61","author":"Horio","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"2020081222332007800_i1543-2165-139-7-888-b10","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1515\/CCLM.2010.318","article-title":"First certified reference material for cystatin C in human serum ERM-DA471\/IFCC","volume":"48","author":"Grubb","year":"2010","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"2020081222332007800_i1543-2165-139-7-888-b11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.0954-6820.1985.tb08880.x","article-title":"Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate","volume":"218","author":"Grubb","year":"1985","journal-title":"Acta Med Scand"},{"key":"2020081222332007800_i1543-2165-139-7-888-b12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/00365510802150067","article-title":"Standardization of cystatin C: development of primary and secondary reference preparations","volume":"241","author":"Blirup-Jensen","year":"2008","journal-title":"Scand J Clin Lab Invest Suppl"},{"issue":"4","key":"2020081222332007800_i1543-2165-139-7-888-b13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1373\/clinchem.2005.063511","article-title":"Why commutability matters","volume":"52","author":"Miller","year":"2006","journal-title":"Clin Chem"},{"issue":"9","key":"2020081222332007800_i1543-2165-139-7-888-b14","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1373\/clinchem.2013.208785","article-title":"Commutability still matters","volume":"59","author":"Miller","year":"2013","journal-title":"Clin Chem"},{"issue":"12","key":"2020081222332007800_i1543-2165-139-7-888-b15","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1373\/clinchem.2011.168641","article-title":"Proficiency testing\/external quality assessment: current challenges and future directions","volume":"57","author":"Miller","year":"2011","journal-title":"Clin Chem"},{"issue":"5","key":"2020081222332007800_i1543-2165-139-7-888-b16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1373\/clinchem.2010.159848","article-title":"Calibration of the Siemens cystatin C immunoassay has changed over time","volume":"57","author":"Larsson","year":"2011","journal-title":"Clin Chem"},{"issue":"4","key":"2020081222332007800_i1543-2165-139-7-888-b17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.ajkd.2011.05.019","article-title":"Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values","volume":"58","author":"Inker","year":"2011","journal-title":"Am J Kidney Dis"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/139\/7\/888\/2376706\/arpa_2014-0427-cp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/139\/7\/888\/2376706\/arpa_2014-0427-cp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:34:24Z","timestamp":1764790464000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/139\/7\/article-p888.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,17]]},"references-count":17,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,4,17]]},"published-print":{"date-parts":[[2015,7,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2014-0427-cp","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4,17]]}}}